review article | Q7318358 |
scholarly article | Q13442814 |
P356 | DOI | 10.1111/J.1749-6632.1994.TB56831.X |
P8608 | Fatcat ID | release_2oygevm5yfe4hni7bv4uncelym |
P698 | PubMed publication ID | 8010595 |
P2093 | author name string | Meier-Ruge W | |
Bertoni-Freddari C | |||
Iwangoff P | |||
P2860 | cites work | Morphological adaptive response of the synaptic junctional zones in the human dentate gyrus during aging and Alzheimer's disease | Q44507117 |
Enlargement of synaptic size as a compensative reaction in aging and dementia | Q47411702 | ||
Alzheimer plaque density and duration of dementia | Q47981280 | ||
The electroencephalogram in the middle-aged and the elderly | Q48302986 | ||
Neocortical metabolic abnormalities precede nonmemory cognitive defects in early Alzheimer's-type dementia | Q48305999 | ||
Positron emission tomography in Alzheimer's disease | Q48328045 | ||
βA4 amyloid protein deposition in brain after head trauma | Q48611315 | ||
Neurochemical enzyme changes in Alzheimer's and Pick's disease | Q48655012 | ||
The fluorodeoxyglucose 18F scan in Alzheimer's disease and multi-infarct dementia | Q48719942 | ||
Deposition of ?/A4 protein along neuronal plasma membranes in diffuse senile plaques | Q48819449 | ||
Changes in Na+,K(+)-ATPase, Ca2(+)-ATPase and some soluble enzymes related to energy metabolism in brains of patients with Alzheimer's disease. | Q53129399 | ||
Targeting of cell-surface beta-amyloid precursor protein to lysosomes: alternative processing into amyloid-bearing fragments. | Q53180704 | ||
Glycolytic enzymes from human autoptic brain cortex: Normal aged and demented cases | Q53196953 | ||
Abnormalities of Glucose Metabolism in Alzheimer's Disease | Q53295728 | ||
Abnormalities of Energy Metabolism in Alzheimer's Disease Studied with PETa | Q53295731 | ||
Genetic linkage studies suggest that Alzheimer's disease is not a single homogeneous disorder. | Q53299482 | ||
DNA repair and transcription: the helicase connection. | Q54659177 | ||
Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease | Q28241772 | ||
Early-onset Alzheimer's disease caused by mutations at codon 717 of the beta-amyloid precursor protein gene | Q28245149 | ||
Phosphorylation of Alzheimer disease amyloid precursor peptide by protein kinase C and Ca2+/calmodulin-dependent protein kinase II. | Q33642350 | ||
Beta-amyloid precursor protein of Alzheimer disease occurs as 110- to 135-kilodalton membrane-associated proteins in neural and nonneural tissues. | Q33652573 | ||
Normal Processing of the Alzheimer's Disease Amyloid β Protein Precursor Generates Potentially Amyloidogenic Carboxyl‐Terminal Derivatives | Q35186129 | ||
Protein Metabolism in the Brain | Q35186133 | ||
The Involvement of Proteases, Protease Inhibitors, and an Acute Phase Response in Alzheimer's Disease a | Q35186145 | ||
Degradation of proteins in the membrane-cytoskeleton complex in Alzheimer's disease. Might amyloidogenic APP processing be just the tip of the iceberg? | Q35186155 | ||
Selective Degradation of Cytosolic Proteins by Lysosomesa | Q35186192 | ||
The role of amyloid beta-protein in Alzheimer's disease | Q35263353 | ||
Characterization of alternative routes for processing of the Alzheimer beta/A4-amyloid precursor protein. Differential effects of phorbol esters and chloroquine | Q35277863 | ||
Alzheimer's disease: a cell biological perspective | Q36129542 | ||
Mechanisms of amyloid deposition in Alzheimer's disease. | Q36927540 | ||
Protein phosphorylation regulates secretion of Alzheimer beta/A4 amyloid precursor protein | Q36935627 | ||
Precursor of amyloid protein in Alzheimer disease undergoes fast anterograde axonal transport | Q37701379 | ||
Molecular pathology of amyloidogenic proteins and the role of vascular amyloidosis in Alzheimer's disease | Q38237598 | ||
ATP and brain function | Q38597443 | ||
Quantitative changes in some subcortical nuclei in aging, Alzheimer's disease and Parkinson's disease | Q39691524 | ||
Regulation of acetylcholine synthesis in the brain | Q39813182 | ||
Mitochondrial genetics: a paradigm for aging and degenerative diseases? | Q41112226 | ||
Senile dementia: a threshold phenomenon of normal aging? A contribution to the functional reserve hypothesis of the brain | Q41163764 | ||
Production of the Alzheimer amyloid beta protein by normal proteolytic processing | Q41599298 | ||
Potentially Amyloidogenic, Carboxyl-Terminal Derivatives of the Amyloid Protein Precursor | Q41640200 | ||
Morphometric investigation of nerve cells, neuropil and senile plaques in senile dementia of the Alzheimer type | Q44402633 | ||
P407 | language of work or name | English | Q1860 |
P921 | main subject | Alzheimer's disease | Q11081 |
P304 | page(s) | 230-237 | |
P577 | publication date | 1994-05-01 | |
P1433 | published in | Annals of the New York Academy of Sciences | Q2431664 |
P1476 | title | What is primary and what secondary for amyloid deposition in Alzheimer's disease | |
P478 | volume | 719 |
Q70975187 | A heterogeneous set of urea-insoluble proteins in dividing PC12 pheochromocytoma cells is passed on to at least the generation of great-granddaughter cells |
Q37075513 | Can Ketones Help Rescue Brain Fuel Supply in Later Life? Implications for Cognitive Health during Aging and the Treatment of Alzheimer's Disease |
Q44210278 | Changes in activity and expression of phosphofructokinase in different rat brain regions after basal forebrain cholinergic lesion |
Q54128012 | Distribution of beta-amyloid and amyloid precursor protein in the brain of spawning (senescent) salmon: a natural, brain-aging model. |
Q48626465 | Effect of Tiantai No.1 on gene expression profiles in hippocampus of Alzheimer's disease rats by bioinformatic analysis |
Q52030086 | Improvement of cerebral ATP and choline deficiencies by Shao-Yin-Ren Shi-Quang-Da-Bu-Tang in senescence-accelerated mouse prone 8. |
Q44417010 | Interrelationships among brain, endocrine and immune response in ageing and successful ageing: role of metallothionein III isoform |
Q60459099 | Modulating Effects of Nutrition on Brain Ageing |
Q28200789 | The creatine kinase/creatine connection to Alzheimer's disease: CK-inactivation, APP-CK complexes and focal creatine deposits |
Q41060580 | The significance of glucose turnover in the brain in the pathogenetic mechanisms of Alzheimer's disease |